Alnylam Pharmaceuticals Inc (ALNY) — Long-term Investment Intensity
Alnylam Pharmaceuticals Inc (ALNY) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of $14.82 Million represent 0.6% of total assets of $2.40 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Alnylam Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Alnylam Pharmaceuticals Inc Long-term Investment Intensity (2010–2019)
This chart shows how Alnylam Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2010 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of $14.82 Million against total assets of $2.40 Billion USD. See Alnylam Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Alnylam Pharmaceuticals Inc (2010–2019)
The table below presents the year-by-year Long-term Investment Intensity for Alnylam Pharmaceuticals Inc from 2010 to 2019, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Alnylam Pharmaceuticals Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.6% | $14.82 Million | $2.40 Billion | ▼ -0.1 pp |
| 2017 | 0.7% | $13.92 Million | $1.99 Billion | ▼ -25.0 pp |
| 2016 | 25.7% | $324.80 Million | $1.26 Billion | ▲ +7.6 pp |
| 2015 | 18.2% | $251.84 Million | $1.39 Billion | ▼ -7.8 pp |
| 2014 | 25.9% | $279.82 Million | $1.08 Billion | ▼ -9.8 pp |
| 2013 | 35.7% | $150.05 Million | $420.53 Million | ▼ -0.3 pp |
| 2012 | 36.0% | $103.42 Million | $287.52 Million | ▼ -4.8 pp |
| 2011 | 40.8% | $114.97 Million | $281.92 Million | ▲ +10.2 pp |
| 2010 | 30.6% | $120.39 Million | $393.26 Million | — |